Long non-coding RNAs associated with non-small cell lung cancer

Yuting Zhan; Hongjing Zang; Juan Feng; Junmi Lu; Lingjiao Chen; Songqing Fan

doi:10.18632/oncotarget.20088

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Long non-coding RNAs associated with non-small cell lung cancer

Yuting Zhan, Hongjing Zang, Juan Feng, Junmi Lu, Lingjiao Chen and Songqing Fan _

PDF | HTML | How to cite

Oncotarget. 2017; 8:69174-69184. https://doi.org/10.18632/oncotarget.20088

Metrics: PDF 1454 views | HTML 2710 views | ?

Abstract

Yuting Zhan1, Hongjing Zang1, Juan Feng1, Junmi Lu1, Lingjiao Chen1 and Songqing Fan1

1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Correspondence to:

Songqing Fan, email: [email protected]

Keywords: NSCLC, lncRNAs, chemotherapy, radiotherapy, molecular therapy

Received: May 01, 2017 Accepted: July 26, 2017 Published: August 09, 2017

ABSTRACT

Lung cancer, with 80–85% being non-small cell lung cancer (NSCLC), is the leading cause of cancer-related death in both men and women. Long non-coding RNAs (lncRNAs), always defined as non-protein-coding RNA molecules longer than 200 nucleotides, are now thought as a new frontier in the study of human malignant diseases including NSCLC. As researches continue, increasing number of roles that lncRNAs play in NSCLC has been found, and more and more evidences show lncRNAs have a close relationship with patients’ response to radiochemotherapy or molecular therapy. The aim of this review is to disclose the roles that lncRNAs play in NSCLC and how lncRANs influence the treatment of NSCLC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20088

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Long non-coding RNAs associated with non-small cell lung cancer

Abstract